YC P25
Frekil
RWE Generation in minutes
About
Today, it takes months to understand how drugs perform in the real world, delaying safety insights and leaving patients exposed to unknown risks and benefits for far too long. Frekil turns that months-long process into minutes, with full auditability and scientific rigor. Frekil accelerates real world evidence (RWE) generation for life sciences companies on their own clinical data from months to minutes. It connects to fragmented clinical data (EHR, Claims, etc.) and lets teams run end-to-end studies from study design, cohort extraction to SAP, statistical analysis, and final reports.
Founders
- Nikhil Tiwari
- Shivesh Gupta
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Frekil.
See family office activityIndustry & Focus
HealthcareHealth TechB2BBiotechAI